Investigation of the Effects of Edaravone on Valproic Acid Induced Tissue Damage in Pancreas

Oktay S., Alev-Tuzuner B., Tunali S., AK E., Emekli-Alturfan E. I., Tunali-Akbay T., ...Daha Fazla

MARMARA PHARMACEUTICAL JOURNAL, cilt.21, sa.3, ss.570-577, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.12991/marupj.319312
  • Dergi Adı: MARMARA PHARMACEUTICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.570-577
  • Anahtar Kelimeler: Valproic acid, edaravone, pancreas, tissue damage, antioxidant and oxidant parameters, FREE-RADICAL SCAVENGER, OXIDATIVE STRESS, ADULTS, BLOOD, PLASMA, HEALTH, ASSAY
  • Marmara Üniversitesi Adresli: Evet

Özet

Valproic acid (VPA), an effective antiepileptic and anticonvulsant drug, has some toxic side effects due to causing elevated oxidant production. The aim of this study is to investigate the effects of edaravone, a potent free radical scavenger on VPA induced toxicity and tissue damage by biochemical and histological examinations on pancreas. Female Sprague Dawley rats were divided into four groups as follows; control, edaravone, VPA, VPA+edaravon. VPA and edaravone were injected intraperitonally for seven days. Total protein, lipid peroxidation (LPO), sialic acid (SA) and glutathione (GSH) levels and alkaline phosphatase (ALP), tissue factor (TF), superoxide dismutase (SOD), glutathione-S-transferase GST), catalase (CAT), glutathione peroxidase (GPx) and myeloperoxidase (MPO) activities were determined in pancreas homogenates. In VPA given group, LPO and SA levels, and ALP, TF, MPO activities significantly increased and GST, CAT, GPx activities significantly decreased compared to control group. A marked morphological damage was detected in the VPA group. Ameliorative effects of edaravone were observed in SA, TF, CAT, GPx parameters and histological examination in the VPA group. Therefore, edaravone may be effective in moderation and/or reduction of toxic effects of VPA on pancreas.